BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38872409)

  • 1. An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.
    Wijnands C; Armony G; Noori S; Gloerich J; Bonifay V; Caillon H; Luider TM; Brehmer S; Pfennig L; Srikumar T; Trede D; Kruppa G; Dejoie T; van Duijn MM; van Gool AJ; Jacobs JFM; Wessels HJCT
    Clin Chem Lab Med; 2024 Jun; ():. PubMed ID: 38872409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Data-Dependent Acquisition, Data-Independent Acquisition, and Parallel Reaction Monitoring in Trapped Ion Mobility Spectrometry-Time-of-Flight Tandem Mass Spectrometry-Based Lipidomics.
    Rudt E; Feldhaus M; Margraf CG; Schlehuber S; Schubert A; Heuckeroth S; Karst U; Jeck V; Meyer SW; Korf A; Hayen H
    Anal Chem; 2023 Jun; 95(25):9488-9496. PubMed ID: 37307407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing taxonomic and functional characterization of host-microbiome interactions by DIA-PASEF metaproteomics.
    Gómez-Varela D; Xian F; Grundtner S; Sondermann JR; Carta G; Schmidt M
    Front Microbiol; 2023; 14():1258703. PubMed ID: 37908546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of 782 Plasma Peptides by Multiplexed Targeted Proteomics.
    Lesur A; Bernardin F; Koncina E; Letellier E; Kruppa G; Schmit PO; Dittmar G
    J Proteome Res; 2023 Jun; 22(6):1630-1638. PubMed ID: 37011904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
    Wijnands C; Langerhorst P; Noori S; Keizer-Garritsen J; Wessels HJCT; Gloerich J; Bonifay V; Caillon H; Luider TM; van Gool AJ; Dejoie T; VanDuijn MM; Jacobs JFM
    Clin Chem Lab Med; 2024 Feb; 62(3):540-550. PubMed ID: 37823394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow.
    Langerhorst P; Noori S; Zajec M; De Rijke YB; Gloerich J; van Gool AJ; Caillon H; Joosten I; Luider TM; Corre J; VanDuijn MM; Dejoie T; Jacobs JFM
    Clin Chem; 2021 Nov; 67(12):1689-1698. PubMed ID: 34643690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parallel Reaction Monitoring-Parallel Accumulation-Serial Fragmentation (prm-PASEF) Approach for Multiplexed Absolute Quantitation of Proteins in Human Plasma.
    Brzhozovskiy A; Kononikhin A; Bugrova AE; Kovalev GI; Schmit PO; Kruppa G; Nikolaev EN; Borchers CH
    Anal Chem; 2022 Feb; 94(4):2016-2022. PubMed ID: 35040635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-dimensional proteomics analysis of human cerebrospinal fluid with trapped ion mobility spectrometry using PASEF.
    Mun DG; Budhraja R; Bhat FA; Zenka RM; Johnson KL; Moghekar A; Pandey A
    Proteomics; 2023 May; 23(10):e2200507. PubMed ID: 36752121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and In-Depth Coverage of the (Phospho-)Proteome With Deep Libraries and Optimal Window Design for dia-PASEF.
    Skowronek P; Thielert M; Voytik E; Tanzer MC; Hansen FM; Willems S; Karayel O; Brunner AD; Meier F; Mann M
    Mol Cell Proteomics; 2022 Sep; 21(9):100279. PubMed ID: 35944843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical potential of prm-PASEF mass spectrometry.
    Lesur A; Dittmar G
    Expert Rev Proteomics; 2021 Feb; 18(2):75-82. PubMed ID: 33874828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Mass Spectrometry-Based Proteomics with dia-PASEF.
    Skowronek P; Meier F
    Methods Mol Biol; 2022; 2456():15-27. PubMed ID: 35612732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic datasets of HeLa and SiHa cell lines acquired by DDA-PASEF and diaPASEF.
    Huang Z; Kong W; Wong BJ; Gao H; Guo T; Liu X; Du X; Wong L; Goh WWB
    Data Brief; 2022 Apr; 41():107919. PubMed ID: 35198691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchro-PASEF Allows Precursor-Specific Fragment Ion Extraction and Interference Removal in Data-Independent Acquisition.
    Skowronek P; Krohs F; Lubeck M; Wallmann G; Itang ECM; Koval P; Wahle M; Thielert M; Meier F; Willems S; Raether O; Mann M
    Mol Cell Proteomics; 2023 Feb; 22(2):100489. PubMed ID: 36566012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Workflow for Improved Analysis of Cross-Linking Mass Spectrometry Data Integrating Parallel Accumulation-Serial Fragmentation with MeroX and Skyline.
    Rojas Echeverri JC; Hause F; Iacobucci C; Ihling CH; Tänzler D; Shulman N; Riffle M; MacLean BX; Sinz A
    Anal Chem; 2024 May; 96(19):7373-7379. PubMed ID: 38696819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobility-resolved broadband dissociation and parallel reaction monitoring for laser desorption/ionization-mass spectrometry - Tattoo pigment identification supported by trapped ion mobility spectrometry.
    Wolf C; Behrens A; Brungs C; Mende ED; Lenz M; Piechutta PC; Roblick C; Karst U
    Anal Chim Acta; 2023 Feb; 1242():340796. PubMed ID: 36657890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).
    Fan H; Wang B; Shi L; Pan N; Yan W; Xu J; Gong L; Li L; Liu Y; Du C; Cui J; Zhu G; Deng S; Sui W; Xu Y; Yi S; Hao M; Zou D; Chen X; Qiu L; An G
    Clin Cancer Res; 2024 Mar; 30(6):1131-1142. PubMed ID: 38170583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma.
    Langerhorst P; Brinkman AB; VanDuijn MM; Wessels HJCT; Groenen PJTA; Joosten I; van Gool AJ; Gloerich J; Scheijen B; Jacobs JFM
    Clin Chem; 2021 Jun; 67(6):867-875. PubMed ID: 33709101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts.
    Demichev V; Szyrwiel L; Yu F; Teo GC; Rosenberger G; Niewienda A; Ludwig D; Decker J; Kaspar-Schoenefeld S; Lilley KS; Mülleder M; Nesvizhskii AI; Ralser M
    Nat Commun; 2022 Jul; 13(1):3944. PubMed ID: 35803928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
    Pak H; Michaux J; Huber F; Chong C; Stevenson BJ; Müller M; Coukos G; Bassani-Sternberg M
    Mol Cell Proteomics; 2021; 20():100080. PubMed ID: 33845167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.